Wei Miao is a Chinese national currently pursuing a PhD in Biomedical Science at KU Leuven in Belgium. His PhD topic is focused on controlling the immune response to adenovirus used in gene therapy. He has over 10 years of experience in fields including cell culture, immunoassays, murine models, and HPLC analysis. Miao holds a Master's degree from KU Leuven and Bachelor's from Tianjin University in China, and has worked as a technician and initiated but did not complete a prior PhD. He is skilled in molecular biology, cell biology, immunology techniques and mouse work.